Biocon sells 80 lacs equity shares of Syngene International for Rs 686 crores Ruchika Sharma12 Dec 2024 5:06 PM ISTBangalore: Biocon has sold Eighty Lacs equity shares of Syngene International Limited for Rs. 686 crores. The transacted value is the gross...
Biocon Foundation Wins 2024 Doing Good for Bharat Award in Healthcare for eLAJ Smart Clinics MD Bureau26 Oct 2024 2:38 PM ISTBengaluru: Biocon Foundation, the CSR arm of the Biocon Group of Companies, announced that it has received the esteemed ‘Doing Good for Bharat...
Torsemide, Dapagliflozin FDC not rational: CDSCO Panel Rejects Syngene's Proposal for BA/BE study Dr. Divya Colin25 Sept 2024 6:00 PM ISTNew Delhi: Noting the proposed fixed-dose combination (FDC) of 24 mg extended-release (ER) Torsemide and 8 mg Dapagliflozin Tablets is not rational;...
Syngene biologics manufacturing facility to be operational for US, European customers from mid year Ruchika Sharma18 March 2024 10:00 AM ISTBangalore: At DCAT 2024 global bio/pharmaceutical manufacturing forum, Syngene International, a global contract research, development and...
Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma Ruchika Sharma4 Dec 2023 3:00 PM ISTBangalore: Syngene International has announced the conclusion of the acquisition of a multi-modal biologics manufacturing facility from Stelis...
Indian drug manufacturers benefit from Big Pharma interest beyond China Ruchika Sharma27 Nov 2023 11:52 AM ISTFour of India's largest CDMOs - Syngene, Aragen Life Sciences, Piramal Pharma Solutions, and Sai Life Sciences - told Reuters they have this year seen...
Syngene International reports 14.22 percent increase in net profit at Rs 116.5 crore in Q2 Ruchika Sharma19 Oct 2023 1:30 PM ISTNew Delhi: Syngene International Ltd has reported a 14.22 per cent increase in consolidated net profit at Rs 116.5 crore in the September quarter.The...
Syngene International Gets CDSCO Panel Nod To study Trinbelimab Injection Dr. Divya Colin15 Aug 2023 5:00 PM ISTNew Delhi: Based on the Phase I clinical trial protocol presented by the drug major Synegene International to evaluate the pharmacokinetics and...
Submit Revised protocol for Torsemide ER tablets: CDSCO Tells Syngene Dr. Divya Colin19 July 2023 6:00 PM ISTNew Delhi: Highlighting that proof of concept and criteria are not defined for the overactive bladder in Congestive heart failure (CHF) patients, the...
Syngene profit after tax rises 21 percent at Rs 179 crore in Q4 Ruchika Sharma28 April 2023 2:30 PM ISTRevenue from operations rose to Rs 3,193 crore in FY23 as compared with Rs 2,604 in 2021-22 fiscal.
Syngene Proposal To Conduct Phase I CT of Ferumoxytol Inj rejected by CDSCO panel Dr. Divya Colin26 March 2023 5:30 PM ISTNew Delhi: Stating that the proposal submitted by Syngene International could not be considered at present, the Subject Expert Committee (SEC)...
Biocon raises Rs 1067 crore from Kotak to fund biosimilars deal Ruchika Sharma23 Feb 2023 1:00 PM IST"This investment in Biocon comes at a pivotal point when Biocon is forward integrating its biosimilars business," Srini Sriniwasan, managing director...
